Key Client Fiduciary Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1912612 Fairfield, NJ

Position in AMGN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$370,086

+$11,199 QoQ

Shares Held

1,022

+0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#2,402

of 3,140 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Key Client Fiduciary Advisors, LLC holds $6,120,333 across 7 Drug Manufacturers - General names. AMGN ranks #6 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	5,928	$1,491,721
2	LLY	ELI LILLY & Co	1,195	$1,433,318
3	MRK	Merck & Co., Inc.	7,589	$975,186
4	PFE	Pfizer Inc	31,030	$747,202
5	JNJ	Johnson & Johnson	2,907	$738,290
6	AMGN	Amgen Inc This page	1,022	$370,086
7	NVS	Novartis AG	2,326	$364,530

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$370,086	1,022	+0.2%	Shares	Sole	2026-07-09
2026-03-31	$358,887	1,020	-1.9%	Shares	Sole	2026-04-09
2025-12-31	$340,402	1,040	-10.0%	Shares	Sole	2026-01-28
2025-09-30	$326,223	1,156	-0.3%	Shares	Sole	2025-10-14
2025-06-30	$323,604	1,159	+0.9%	Shares	Sole	2025-07-09
2025-03-31	$357,970	1,149	+1.1%	Shares	Sole	2025-04-10
2024-12-31	$296,347	1,137	+1.5%	Shares	Sole	2025-01-17
2024-09-30	$360,875	1,120	-2.6%	Shares	Sole	2024-10-18
2024-06-30	$359,317	1,150	+1.4%	Shares	Sole	2024-07-16
2024-03-31	$322,418	1,134	+18.0%	Shares	Sole	2024-04-15
2023-12-31	$276,787	961	-4.7%	Shares	Sole	2024-01-09
2023-09-30	$270,910	1,008	+0.5%	Shares	Sole	2023-11-14
2023-06-30	$222,686	1,003	+3.6%	Shares	Sole	2023-07-13
2023-03-31	$234,014	968	+4.3%	Shares	Sole	2023-04-25
2022-12-31	$243,729	928	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.